Search Results

Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care

Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, proudly announces the successful completion of its acquisition of Volpara Health Technologies, a global leader in medical software for breast cancer screening.

May 22, 2024

·

4 min read

Deals

Update on Lunit’s Acquisition of Volpara: New Zealand High Court Initial Approval Secured

Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a significant update on its acquisition of Volpara Health Technologies.

March 13, 2024

·

4 min read

Deals

Volpara Health enters agreement to be acquired by Lunit, Inc.

Volpara Health Technologies (“Volpara,” “the Group,” or “the Company"; ASX:VHT), a global leader in software for the early detection of breast cancer, is pleased to announce it has entered into an agreement to be acquired by Lunit Inc.

December 13, 2023

·

3 min read

BioForest

Volpara to Showcase AI Software for Breast Centers at NCBC 2024, Including Lunit INSIGHT for Early Detection

Volpara Health Technologies Ltd. will showcase its latest software advancements for breast centers at the 2024 National Consortium of Breast Centers (NCBC) conference, March 15-19 in Las Vegas.

March 15, 2024

·

4 min read

Deals

Lunit to Acquire Volpara: Scheme Implementation Agreement Signed

Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its proposal to acquire Volpara Health Technologies Ltd., a global leader in AI-enabled software for the early detection and prevention of cancer.

December 14, 2023

·

5 min read

BioForest

Volpara Health breast density and mammography quality software highlighted in new peer-reviewed research

Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection and prevention of cancer, was featured in two peer reviewed studies published during this year’s Radiological Society of North America (RSNA) annual meeting.

December 20, 2023

·

4 min read

BioForest

Volpara to showcase comprehensive product offerings at NCoBC 2023

Volpara Health Technologies Ltd., a global leader in software for the early detection of cancer, is attending this year’s National Consortium of Breast Centers conference in Las Vegas to showcase its software advancements that are powering ‘s progressive breast centers.

March 23, 2023

·

5 min read

BioForest

Volpara highlights cancer risk assessment, breast density assessment and mammography quality software at SBI 2023

Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, is attending the 2023 Society of Breast Imaging annual symposium, May 4-7 in Maryland.

May 3, 2023

·

4 min read

BioForest

New Research at ECR 2023 Uses Volpara AI to Personalize, Optimize Breast Cancer Detection

Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, was highlighted in research presented at the 2023 European Congress of Radiology (ECR).

March 8, 2023

·

5 min read

Policy

FDA Breast Density Reporting Rule is a Critical Step for Women says Volpara Health, the Leader in AI-assisted Breast Density Measurement

Volpara Health Technologies, a global leader in software for the early detection of breast cancer, announced that a new US federal regulation was finalized by the US Food and Drug Administration requiring mammography facilities across the country to inform patients whether their breasts are composed of dense tissue.

March 10, 2023

·

5 min read